MDL 63246

a semisynthetic glycopeptide; structure given in first source

Also Known As:

Hepta-tyr; MDL 63,246; MDL-63,246; MDL-63246

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/08/2004 - "Hepta-Tyr antibiotic modified silica stationary phase was used for the chiral resolution of D,L-loxiglumide, a new drug under investigation proposed for the treatment of gastrointestinal diseases. "
2.	Body Weight (Weight, Body) 10/01/1995 - "The pharmacokinetics of MDL 63,246 in the rat appear to be dose proportional in the dose range of 20 to 50 mg/kg of body weight. "

1.	Silicon Dioxide (Silica)
2.	Anti-Bacterial Agents (Antibiotics)
3.	loxiglumide